Screener
PTC Therapeutics PTCT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Finance lease liabilities- current | 6,000 | 3,000 |
| Liability for sale of future royalties- current | 305,041 | 283,000 |
| Total current liabilities | 923,604 | 968,427 |
| Operating lease liabilities- noncurrent | 90,072 | 93,583 |
| Finance lease liabilities- noncurrent | — | 3,000 |
| Liability for sale of future royalties- noncurrent | 2,022,189 | 2,025,366 |
| Other long-term liabilities | 13,704 | 13,704 |
| Total liabilities | 3,049,569 | 3,104,080 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's operating lease liabilities?
- PTC Therapeutics (PTCT) reported operating lease liabilities of $90.07M in Q1 2026.
- How has PTC Therapeutics's operating lease liabilities changed year-over-year?
- PTC Therapeutics's operating lease liabilities increased by 22.4% year-over-year, from $73.56M to $90.07M.
- What is the long-term trend for PTC Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), PTC Therapeutics's operating lease liabilities has grown at a 3.3% compound annual growth rate (CAGR), from $79.5M to $93.58M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about PTC Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude